These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33134483)

  • 1. Practice Habits, Knowledge, and Attitudes of Hepatologists to Alcohol Use Disorder Medication: Sobering Gaps and Opportunities.
    Cotter TG; Ayoub F; King AC; Reddy KG; Charlton M
    Transplant Direct; 2020 Oct; 6(10):e603. PubMed ID: 33134483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group.
    Im GY; Mellinger JL; Winters A; Aby ES; Lominadze Z; Rice J; Lucey MR; Arab JP; Goel A; Jophlin LL; Sherman CB; Parker R; Chen PH; Devuni D; Sidhu S; Dunn W; Szabo G; Singal AK; Shah VH
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2407-2416.e8. PubMed ID: 33069880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of Addiction Specialists' Use of Medications to Treat Alcohol Use Disorder.
    Ehrie J; Hartwell EE; Morris PE; Mark TL; Kranzler HR
    Front Psychiatry; 2020; 11():47. PubMed ID: 32116860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics.
    Williams EC; Achtmeyer CE; Young JP; Berger D; Curran G; Bradley KA; Richards J; Siegel MB; Ludman EJ; Lapham GT; Forehand M; Harris AHS
    J Gen Intern Med; 2018 Mar; 33(3):258-267. PubMed ID: 29086341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes.
    Hagedorn HJ; Wisdom JP; Gerould H; Pinsker E; Brown R; Dawes M; Dieperink E; Myrick DH; Oliva EM; Wagner TH; Harris AHS
    Addict Sci Clin Pract; 2019 Jul; 14(1):24. PubMed ID: 31291996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Primary Care Providers' Perceptions of Alcohol Use Disorder And Pharmacotherapy Prescribing Rates.
    Bernstein EY; Pfoh ER; Le P; Rothberg MB
    Alcohol Alcohol; 2023 Jan; 58(1):54-59. PubMed ID: 36368012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of a clinical pharmacy specialist into a substance use disorder intensive outpatient treatment program to improve prescribing rates of alcohol use disorder pharmacotherapy.
    Dimitropoulos E; Bertucci S; Wong K
    Subst Abus; 2018; 39(2):190-192. PubMed ID: 29558338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line Medications for the Outpatient Treatment of Alcohol Use Disorder: A Systematic Review of Perceived Barriers.
    Gregory C; Chorny Y; McLeod SL; Mohindra R
    J Addict Med; 2022 Jul-Aug 01; 16(4):e210-e218. PubMed ID: 34561352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development and evaluation of a provider-focused educational intervention about alcohol use disorder in patients with cirrhosis.
    Johnson E; Ghosh M; Daniels VJ; Wild TC; Campbell-Scherer D; Mellinger J; Winder GS; Fernandez AC; Kirkwood J; Tandon P
    Can Liver J; 2023 Oct; 6(3):295-304. PubMed ID: 38020191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the Hepatology Workforce in the United States: A Predicted Critical Shortage.
    Russo MW; Fix OK; Koteish AA; Duggan K; Ditmyer M; Fuchs M; Chung RT; Reddy G
    Hepatology; 2020 Oct; 72(4):1444-1454. PubMed ID: 32898922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Care Providers' Interest in Using a Genetic Test to Guide Alcohol Use Disorder Treatment.
    Williams EC; Young JP; Achtmeyer CE; Hendershot CS
    J Subst Abuse Treat; 2016 Nov; 70():14-20. PubMed ID: 27692183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidisciplinary Care of Alcohol-related Liver Disease and Alcohol Use Disorder: A Narrative Review for Hepatology and Addiction Clinicians.
    Shroff H; Gallagher H
    Clin Ther; 2023 Dec; 45(12):1177-1188. PubMed ID: 37813775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD).
    Joudrey PJ; Kladney M; Cunningham CO; Bachhuber MA
    Addict Sci Clin Pract; 2019 May; 14(1):19. PubMed ID: 31039820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
    Williams EC; Matson TE; Harris AHS
    Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.